⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oseltamivir Carboxylate SCHEMBL28431271 | 1.00 | — | — | |
| Oseltamivir Carboxylate SCHEMBL12820854 | 1.00 | — | — | |
| Oseltamivir Carboxylate SCHEMBL4563861 | 1.00 | — | — | |
| Oseltamivir Carboxylate SCHEMBL28433596 | 1.00 | — | — | |
| Oseltamivir Carboxylate SCHEMBL17889878 | 1.00 | — | — | |
| Oseltamivir Carboxylate SCHEMBL14080012 | 1.00 | — | — | |
| Oseltamivir Carboxylate SCHEMBL13968374 | 1.00 | — | — | |
| Oseltamivir Carboxylate SCHEMBL1977050 | 1.00 | — | — | |
| Oseltamivir Carboxylate SCHEMBL20607528 | 1.00 | — | — | |
| Oseltamivir Carboxylate SCHEMBL28438495 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116699013-A | Method for separating and detecting related impurities in oseltamium phosphate Wei Kou disintegrating tablet | 北京星昊医药股份有限公司 | 2023-09-05 | — | — | CN | claimed |
| US-11684603-B2 | Neuraminidase inhibition to improve glycocalyx volume and function to ameliorate cardiovascular diseases in pathologies associated with glycocalyx damage | CURATORS OF THE UNIVERSITY OF MISSOURI UNIVERSITY (US) | 2023-06-27 | — | — | US | claimed |
| US-20210186921-A1 | NEURAMINIDASE INHIBITION TO IMPROVE GLYCOCALYX VOLUME AND FUNCTION TO AMELIORATE CARDIOVASCULAR DISEASES IN PATHOLOGIES ASSOCIATED WITH GLYCOCALYX DAMAGE | CURATORS OF THE UNIVERSITY OF MISSOURI | 2021-06-24 | — | — | US | claimed |
| CN-111793045-B | Oxabicyclo [4.1.0] heptane-1-carboxylic acid derivatives, their preparation, compositions and uses | 中山万远新药研发有限公司 | 2021-04-16 | — | — | CN | claimed |
| CN-111793045-A | Oxabicyclo [4.1.0] heptane-1-carboxylic acid derivatives, their preparation, compositions and uses | 中山万远新药研发有限公司 | 2020-10-20 | — | — | CN | claimed |
| CN-111517978-A | cyclohexenyl-DL-aspartic acid derivative, preparation method, composition and application thereof | 中山万汉制药有限公司 | 2020-08-11 | — | — | CN | claimed |
| CN-111470999-A | N-cyclohexenyl-fatty amide compound and preparation method, composition and application thereof | 中山万汉制药有限公司 | 2020-07-31 | — | — | CN | claimed |
| US-20190200602-A1 | Platelet Additive Solution Having a Beta-Galactosidase Inhibitor | VELICO MEDICAL, INC. (US) | 2019-07-04 | — | — | US | claimed |
| US-10271541-B2 | Platelet additive solution having a beta-galactosidase inhibitor | VELICO MEDICAL, INC (US) | 2019-04-30 | — | — | US | claimed |
| US-20190054060-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLUENZA VIRUS | VERSITECH LIMITED (HK) | 2019-02-21 | — | — | US | claimed |
| US-20120321722-A1 | Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor | VELICO MEDICAL, INC | 2012-12-20 | — | — | US | claimed |
| US-20120321601-A1 | Increased In Vivo Circulation Time of Platelets After Storage With A Sialidase Inhibitor | VELICO MEDICAL, INC | 2012-12-20 | — | — | US | claimed |
| US-20120294842-A1 | Platelet Additive Solution Having a Sialidase Inhibitor | VELICO MEDICAL, INC | 2012-11-22 | — | — | US | claimed |
| WO-2012158983-A2 | IMPROVED PLATELET STORAGE USING A SIALIDASE INHIBITOR | LIU QIYONG PETER (US) | 2012-11-22 | — | — | WO | claimed |
| EP-1606242-B1 | AZIDE FREE PROCESS FOR PREPARING 1,2-DIAMINO COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2007-03-14 | — | — | EP | claimed |
| US-7122684-B2 | Process for preparing 1,2-diamino compounds | ROCHE COLORADO CORPORATION (US) | 2006-10-17 | — | — | US | claimed |
| EP-1606242-A1 | AZIDE FREE PROCESS FOR PREPARING 1,2-DIAMINO COMPOUNDS | F.HOFFMANN-LA ROCHE AG (CH) | 2005-12-21 | — | — | EP | claimed |
| WO-2004080944-A1 | AZIDE FREE PROCESS FOR PREPARING 1,2-DIAMINO COMPOUNDS | F.HOFFMANN-LA ROCHE AG (CH) | 2004-09-23 | — | — | WO | claimed |
| US-20040180933-A1 | Process for preparing 1,2-diamino compounds | ROCHE PALO ALTO LLC | 2004-09-16 | — | — | US | claimed |
| EP-0885391-B1 | METHOD OF DETECTION OF INFLUENZA VIRUS AND COMPOUNDS FOR USE THEREIN | BIOTA SCIENT MANAGEMENT (AU) | 2003-04-23 | — | — | EP | claimed |